Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
85.50
-2.38 (-2.71%)
Jan 22, 2026, 3:00 PM CST
29.35% (1Y)
| Market Cap | 23.26B |
| Revenue (ttm) | 742.28M |
| Net Income (ttm) | -133.34M |
| Shares Out | 264.71M |
| EPS (ttm) | -0.50 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,075,055 |
| Average Volume | 3,391,781 |
| Open | 87.88 |
| Previous Close | 87.88 |
| Day's Range | 84.98 - 88.88 |
| 52-Week Range | 62.68 - 134.17 |
| Beta | 0.31 |
| RSI | 33.27 |
| Earnings Date | Mar 28, 2026 |